2026年2月9日,全球知名生物制药企业Sobi宣布完成对Arthrosi Therapeutics的收购。这笔交易背后,是一款痛风创新药8年的破局之路。作为Arthrosi的早期投资方与孵化伙伴,维亚生物见证并陪伴了Arthrosi从创立到被收购的完整历程。今天,VIVA会客厅独家专访Arthrosi联合创始人兼首席运营官颜顺启博士,听他讲述这场收购背后的故事。Q:都说初创公司三年是个坎,能否...
Source Link2026年2月9日,全球知名生物制药企业Sobi宣布完成对Arthrosi Therapeutics的收购。这笔交易背后,是一款痛风创新药8年的破局之路。作为Arthrosi的早期投资方与孵化伙伴,维亚生物见证并陪伴了Arthrosi从创立到被收购的完整历程。今天,VIVA会客厅独家专访Arthrosi联合创始人兼首席运营官颜顺启博士,听他讲述这场收购背后的故事。Q:都说初创公司三年是个坎,能否...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.